Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours
Cancer Treat Rev. 2003 Dec;29(6):565-9.
doi: 10.1016/j.ctrv.2003.07.002.
1 Division of Hepatology and Gastroenterology & Interdisciplinary, Centre of Endocrinology and Metabolism, Department of Internal Medicine, Charité, Campus Virchow Klinikum, Berlin, Germany.